Catherine Lynch - BlackRock Science Independent Trustee
BST Etf | USD 36.68 0.23 0.63% |
Age | 60 |
Tenure | 8 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Catherine Lynch Latest Insider Activity
Tracking and analyzing the buying and selling activities of Catherine Lynch against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Catherine Lynch insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Catherine Lynch over three months ago Acquisition by Catherine Lynch of 864 shares of PennyMac Mortgage at 13.295 subject to Rule 16b-3 | ||
Catherine Lynch over three months ago Acquisition by Catherine Lynch of 1172 shares of PennyMac Mortgage at 13.64 subject to Rule 16b-3 | ||
Catherine Lynch over six months ago Insider Trading | ||
Catherine Lynch over six months ago Acquisition by Catherine Lynch of 128 shares of BlackRock Credit subject to Rule 16b-3 |
Similar Fund Executives
Showing other executives | One Year Return | ||
Jay Fife | Blackrock Innovation Growth | 51 | |
Richard Froio | Eaton Vance Enhanced | 53 | |
Deidre Walsh | Eaton Vance Enhanced | 50 | |
Kathleen Anderson | BlackRock Utility Infrastructur | N/A | |
Keith Quinton | Eaton Vance Enhanced | 63 | |
Daniel Beckman | Columbia Seligman Premium | 57 | |
Christopher Accettella | BlackRock Utility Infrastructur | N/A | |
W Kester | BlackRock Health Sciences | 70 | |
Cynthia Egan | Blackrock Innovation Growth | 66 | |
J Holloman | BlackRock Health Sciences | 66 | |
Cynthia Egan | BlackRock Health Sciences | 66 | |
Xiang Liu | BlackRock Health Sciences | N/A | |
Janey Ahn | Blackrock Innovation Growth | 46 | |
Antonio III | BlackRock Utility Infrastructur | 56 | |
Richard Cavanagh | Blackrock Innovation Growth | 75 | |
Stayce Harris | BlackRock Health Sciences | 62 | |
Robert Fairbairn | Blackrock Innovation Growth | 56 | |
Marcus Smith | Eaton Vance Enhanced | 54 | |
Jonathan Diorio | BlackRock Health Sciences | 41 | |
Jeffrey Lee | BlackRock Health Sciences | N/A | |
Robin Batchelor | BlackRock Utility Infrastructur | N/A |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | ||||
Shares Owned By Insiders | 0.01 % | ||||
Shares Owned By Institutions | 18.53 % | ||||
Number Of Shares Shorted | 14.74 K | ||||
Price To Earning | 5.78 X | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | 5.41 X | ||||
Number Of Employees | 17 | ||||
Market Capitalization | 1 B | ||||
Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.